![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 1, 2004.
Revised April 12, 2004.
Accepted for publication April 13, 2004.
7-NICOTINIC ACETYLCHOLINE RECEPTOR-MEDIATED RESPONSES IN XENOPUS OOCYTES
The effects of endogenous and synthetic cannabinoid receptor agonists including 2-arachidonoylglycerol, R-methanandamide, WIN55,212-2, CP55,940 and the psychoactive constituent of marijuana,
9-THC, on the function of homomeric
7 nicotinic ACh receptors expressed in Xenopus oocytes was investigated using the two-electrode voltage-clamp technique. The endogenous cannabinoid receptor ligands 2-arachidonoylglycerol and the metabolically stable analogue of anandamide, R-methanandamide, reversibly inhibited currents evoked with ACh (100 µM) in a concentration-dependent manner (IC50 values of 168 nM and 183 nM, respectively). In contrast, the synthetic cannabinoid receptor agonists CP55,940, WIN55,212-2, and the phytochemical
9-THC did not alter
7 nicotinic ACh receptor function. The inhibition of
7-mediated currents by 2-arachidonylglycerol was found to be non-competitive and voltage-independent. Additional experiments using endocannabinoid metabolites suggested that arachidonic acid, but not ethanolamine or glycerol, could also inhibit the
7-nACh receptor function. Whereas the effects of arachidonic acid were also noncompetitive and voltage-independent, its potency was much lower than 2-AG and anandamide. Results of studies with chimeric
7-nACh-5-HT3 receptors that were comprised of the amino-terminal domain of the
7-nACh receptor and the transmembrane and carboxyl-terminal domains of 5-HT3 receptors indicated that the site of interaction of the endocannabinoids with the
7-nAChR was not located on the N-terminal region of the receptor. These data indicate that cannabinoid receptor ligands that are produced in-situ potently inhibit
7-nACh receptor function, whereas the synthetic cannabinoid ligands, and
9-THC, are without effect or are relatively ineffective at inhibiting these receptors.
Key words:
arachidonic acid, cannabinoids, drug abuse, endocannabinoids, nicotinic receptors, xenopus oocytes
This article has been cited by other articles:
![]() |
U. Baranowska, M. Gothert, R. Rudz, and B. Malinowska Methanandamide Allosterically Inhibits in Vivo the Function of Peripheral Nicotinic Acetylcholine Receptors Containing the {alpha}7-Subunit J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 912 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Spivak, C. R. Lupica, and M. Oz The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schuel and L. J. Burkman A Tale of Two Cells: Endocannabinoid-Signaling Regulates Functions of Neurons and Sperm Biol Reprod, December 1, 2005; 73(6): 1078 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oz, S. N. Jackson, A. S. Woods, M. Morales, and L. Zhang Additive Effects of Endogenous Cannabinoid Anandamide and Ethanol on {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Responses in Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1272 - 1280. [Abstract] [Full Text] [PDF] |
||||